雷特氏症候群的全球市場:各類型，各治療法，各給藥途徑，各終端用戶，各地區的市場規模與預測(2022年～2028年)

本報告提供全球雷特氏症候群市場相關調查分析，市場趨勢，產業分析，COVID-19影響，各市場區隔、各地區的市場分析，企業簡介等資訊。

目錄

第1章 摘要整理

第2章 全球雷特氏症候群市場定義和範圍

第3章 全球雷特氏症候群的市場動態

• 雷特氏症候群市場影響分析(2020年～2028年)

第4章 全球雷特氏症候群市場產業分析

• 波特的5力模式
• PEST分析
• 投資採用模式
• 分析師的推薦事項與結論
• 主要投資機會
• 主要成功策略

第5章 風險評估:COVID-19影響

• COVID-19對產業的整體影響的評估
• COVID-19前、COVID-19後的市場情境

第6章 全球雷特氏症候群市場:各類型

• 市場概述
• 成果、潛在性分析:各類型
• 估計與預測:各類型(2018年～2028年)
• 子區隔分析
  • 典型性的雷特氏症候群
  • 非典型雷特氏症候群

第7章 全球雷特氏症候群市場:各治療法

• 市場概述
• 成果、潛在性分析:各治療法
• 估計與預測:各治療法(2018年～2028年)
• 子區隔分析
  • 投藥
  • 物理治療
  • 作業療法
  • 語言療法
  • 營養支援

第8章 全球雷特氏症候群市場:各給藥途徑

• 市場概述
• 成果、潛在性分析:各給藥途徑
• 估計與預測:各給藥途徑(2018年～2028年)
• 子區隔分析
  • 口服
  • 非口服
  • 其他

第9章 全球雷特氏症候群市場:各終端用戶

• 市場概述
• 成果、潛在性分析:各終端用戶
• 估計與預測:各終端用戶(2018年～2028年)
• 子區隔分析
  • 醫院
  • 專門診所
  • 其他

第10章 全球雷特氏症候群市場:地區分析

• 地區市場概述
• 北美
  • 美國
  • 加拿大
• 歐洲概述
  • 英國
  • 德國
  • 法國
  • 西班牙
  • 義大利
  • 其他歐洲
• 亞太地區概述
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國
  • 其他亞太地區
• 南美概述
  • 巴西
  • 墨西哥
• 其他地區

第11章 競爭資訊

• 主要市場策略
• 企業簡介
  • Merck KGaA(Germany)
  • Eisai Co., Ltd.(Japan)
  • AstraZeneca(U.K.)
  • Sanofi(France)
  • Novartis AG(Switzerland)
  • Abbott(U.S.)
  • F. Hoffmann-La Roche Ltd.(Switzerland)
  • Teva Pharmaceutical Industries Ltd.(Ireland)
  • Pfizer Inc.(U.S.)
  • GlaxoSmithKline plc(U.K.)

第12章 調查流程

Global Rett Syndrome Market is valued approximately USD XX million in 2021 and is anticipated to grow with a healthy growth rate of more than XX % over the forecast period 2022-2028. The Rett Syndrome can be defined as a rare genetic neurological and developmental disorder that affects the development of the brain. Rett syndrome are caused by a mutation (a change in the DNA) in the MECP2 gene. Rett syndrome is mostly found in females and begins between 8 and 11 years of age and progresses with age. There are different symptoms of Rett Syndrome such as slowed head growth, abnormal hand movements, hyperventilating, screaming, and crying for no obvious reason, difficulty with movement and coordination, and a loss of social interaction and communication. The rising prevalence of neurological disorders and increasing per capita healthcare spending as well as recent approvals from regulatory authorities are accelerating the global market demand. For instance, according to Pan American Health Organization (PAHO) estimates - In 2019, globally Neurological disorders accounted for 533,172 deaths. Around 213,129 (40%) deaths reported in men, whereas around 320,043 (60%) deaths were reported in women. Furthermore, as per The National Center for Biotechnology Information, USA - as of 2020, worldwide 1 in 20 000-40 000 people affected by Rett Syndrome. RTT is most common genetic causes of developmental and intellectual impairment in girls and affects up to 1 in 10 000 girls under the age of 12. Moreover, in April 2022, US based Taysha Gene Therapies launched clinical development of its gene replacement therapy named TSHA-102 for treatment of Rett Syndrome. The company decided to conduct clinical trial after it recently received approval of a clinical trial application (CTA) by Health Canada. The Sainte-Justine Mother and Child University Hospital Center, in Montreal, would be the initial sites for clinical trials. Also, growing number of R&D activities in healthcare sector. And surging healthcare infrastructure in emerging economies are anticipated to act as a catalyzing factor for the market demand during the forecast period. However, high treatment cost and stringent government regulations impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Rett Syndrome Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. North America is the leading region across the world in terms of market share owing to growing healthcare expenditure and presence of leading healthcare players in the region. Whereas, Asia Pacific is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as growing awareness towards neurological disorders and increasing penetration of leading healthcare companies in the region, would create lucrative growth prospects for the global Rett Syndrome Market across the Asia Pacific region.

Major market players included in this report are:

Merck KGaA (Germany)

Eisai Co., Ltd. (Japan)

AstraZeneca (U.K.)

Sanofi (France)

Novartis AG (Switzerland)

Abbott (U.S.)

F. Hoffmann-La Roche Ltd. (Switzerland)

Teva Pharmaceutical Industries Ltd. (Ireland)

Pfizer Inc. (U.S.)

GlaxoSmithKline plc (U.K.)

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type

Classic Rett Syndrome

Atypical Rett Syndrome

By Treatment

Medication

Physical Therapy

Occupational Therapy

Speech language Therapy

Nutritional Support

By Route of Administration

Oral

Parenteral

Others

By End User

Hospitals

Specialty Clinics

Others

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Rett Syndrome Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Million)
  • 1.2.1. Global Rett Syndrome Market, by Region, 2020-2028 (USD Million)
  • 1.2.2. Global Rett Syndrome Market, by Type, 2020-2028 (USD Million)
  • 1.2.3. Global Rett Syndrome Market, by Treatment, 2020-2028 (USD Million)
  • 1.2.4. Global Rett Syndrome Market, by Route of Administration, 2020-2028 (USD Million)
  • 1.2.5. Global Rett Syndrome Market, by End User, 2020-2028 (USD Million)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Rett Syndrome Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Rett Syndrome Market Dynamics

• 3.1. Rett Syndrome Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Rising prevalence of neurological disorders.
    • 3.1.1.2. Increasing per capita healthcare spending.
    • 3.1.1.3. Recent approvals from regulatory authorities.
  • 3.1.2. Market Challenges
    • 3.1.2.1. High treatment cost
    • 3.1.2.2. Stringent government regulations.
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Rising number of R&D activities in healthcare sector.
    • 3.1.3.2. Growing healthcare infrastructure in emerging economies.

Chapter 4. Global Rett Syndrome Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Rett Syndrome Market, by Type

• 6.1. Market Snapshot
• 6.2. Global Rett Syndrome Market by Type, Performance - Potential Analysis
• 6.3. Global Rett Syndrome Market Estimates & Forecasts by Type 2018-2028 (USD Million)
• 6.4. Rett Syndrome Market, Sub Segment Analysis
  • 6.4.1. Classic Rett Syndrome
  • 6.4.2. Atypical Rett Syndrome

Chapter 7. Global Rett Syndrome Market, by Treatment

• 7.1. Market Snapshot
• 7.2. Global Rett Syndrome Market by Treatment, Performance - Potential Analysis
• 7.3. Global Rett Syndrome Market Estimates & Forecasts by Treatment 2018-2028 (USD Million)
• 7.4. Rett Syndrome Market, Sub Segment Analysis
  • 7.4.1. Medication
  • 7.4.2. Physical Therapy
  • 7.4.3. Occupational Therapy
  • 7.4.4. Speech language Therapy
  • 7.4.5. Nutritional Support

Chapter 8. Global Rett Syndrome Market, by Route of Administration

• 8.1. Market Snapshot
• 8.2. Global Rett Syndrome Market by Route of Administration, Performance - Potential Analysis
• 8.3. Global Rett Syndrome Market Estimates & Forecasts by Route of Administration 2018-2028 (USD Million)
• 8.4. Rett Syndrome Market, Sub Segment Analysis
  • 8.4.1. Oral
  • 8.4.2. Parenteral
  • 8.4.3. Others

Chapter 9. Global Rett Syndrome Market, by End User

• 9.1. Market Snapshot
• 9.2. Global Rett Syndrome Market by End User, Performance - Potential Analysis
• 9.3. Global Rett Syndrome Market Estimates & Forecasts by End User 2018-2028 (USD Million)
• 9.4. Rett Syndrome Market, Sub Segment Analysis
  • 9.4.1. Hospitals
  • 9.4.2. Specialty Clinics
  • 9.4.3. Others

Chapter 10. Global Rett Syndrome Market, Regional Analysis

• 10.1. Rett Syndrome Market, Regional Market Snapshot
• 10.2. North America Rett Syndrome Market
  • 10.2.1. U.S. Rett Syndrome Market
    • 10.2.1.1. Type estimates & forecasts, 2018-2028
    • 10.2.1.2. Treatment estimates & forecasts, 2018-2028
    • 10.2.1.3. Route of Administration estimates & forecasts, 2018-2028
    • 10.2.1.4. End User estimates & forecasts, 2018-2028
  • 10.2.2. Canada Rett Syndrome Market
• 10.3. Europe Rett Syndrome Market Snapshot
  • 10.3.1. U.K. Rett Syndrome Market
  • 10.3.2. Germany Rett Syndrome Market
  • 10.3.3. France Rett Syndrome Market
  • 10.3.4. Spain Rett Syndrome Market
  • 10.3.5. Italy Rett Syndrome Market
  • 10.3.6. Rest of Europe Rett Syndrome Market
• 10.4. Asia-Pacific Rett Syndrome Market Snapshot
  • 10.4.1. China Rett Syndrome Market
  • 10.4.2. India Rett Syndrome Market
  • 10.4.3. Japan Rett Syndrome Market
  • 10.4.4. Australia Rett Syndrome Market
  • 10.4.5. South Korea Rett Syndrome Market
  • 10.4.6. Rest of Asia Pacific Rett Syndrome Market
• 10.5. Latin America Rett Syndrome Market Snapshot
  • 10.5.1. Brazil Rett Syndrome Market
  • 10.5.2. Mexico Rett Syndrome Market
• 10.6. Rest of The World Rett Syndrome Market

Chapter 11. Competitive Intelligence

• 11.1. Top Market Strategies
• 11.2. Company Profiles
  • 11.2.1. Merck KGaA (Germany)
    • 11.2.1.1. Key Information
    • 11.2.1.2. Overview
    • 11.2.1.3. Financial (Subject to Data Availability)
    • 11.2.1.4. Product Summary
    • 11.2.1.5. Recent Developments
  • 11.2.2. Eisai Co., Ltd. (Japan)
  • 11.2.3. AstraZeneca (U.K.)
  • 11.2.4. Sanofi (France)
  • 11.2.5. Novartis AG (Switzerland)
  • 11.2.6. Abbott (U.S.)
  • 11.2.7. F. Hoffmann-La Roche Ltd. (Switzerland)
  • 11.2.8. Teva Pharmaceutical Industries Ltd. (Ireland)
  • 11.2.9. Pfizer Inc. (U.S.)
  • 11.2.10. GlaxoSmithKline plc (U.K.)

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes
• 12.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Rett Syndrome Market, report scope
• TABLE 2. Global Rett Syndrome Market estimates & forecasts by Region 2018-2028 (USD Million)
• TABLE 3. Global Rett Syndrome Market estimates & forecasts by Type 2018-2028 (USD Million)
• TABLE 4. Global Rett Syndrome Market estimates & forecasts by Treatment 2018-2028 (USD Million)
• TABLE 5. Global Rett Syndrome Market estimates & forecasts by Route of Administration 2018-2028 (USD Million)
• TABLE 6. Global Rett Syndrome Market estimates & forecasts by End User 2018-2028 (USD Million)
• TABLE 7. Global Rett Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 8. Global Rett Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 9. Global Rett Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 10. Global Rett Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 11. Global Rett Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 12. Global Rett Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 13. Global Rett Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 14. Global Rett Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 15. Global Rett Syndrome Market by segment, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 16. Global Rett Syndrome Market by region, estimates & forecasts, 2018-2028 (USD Million)
• TABLE 17. U.S. Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 18. U.S. Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 19. U.S. Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 20. Canada Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 21. Canada Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 22. Canada Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 23. UK Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 24. UK Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 25. UK Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 26. Germany Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 27. Germany Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 28. Germany Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 29. RoE Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 30. RoE Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 31. RoE Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 32. China Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 33. China Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 34. China Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 35. India Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 36. India Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 37. India Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 38. Japan Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 39. Japan Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 40. Japan Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 41. RoAPAC Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 42. RoAPAC Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 43. RoAPAC Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 44. Brazil Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 45. Brazil Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 46. Brazil Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 47. Mexico Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 48. Mexico Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 49. Mexico Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 50. RoLA Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 51. RoLA Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 52. RoLA Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 53. Row Rett Syndrome Market estimates & forecasts, 2018-2028 (USD Million)
• TABLE 54. Row Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 55. Row Rett Syndrome Market estimates & forecasts by segment 2018-2028 (USD Million)
• TABLE 56. List of secondary sources, used in the study of global Rett Syndrome Market
• TABLE 57. List of primary sources, used in the study of global Rett Syndrome Market
• TABLE 58. Years considered for the study
• TABLE 59. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Rett Syndrome Market, research methodology
• FIG 2. Global Rett Syndrome Market, Market estimation techniques
• FIG 3. Global Market size estimates & forecast methods
• FIG 4. Global Rett Syndrome Market, key trends 2021
• FIG 5. Global Rett Syndrome Market, growth prospects 2022-2028
• FIG 6. Global Rett Syndrome Market, porters 5 force model
• FIG 7. Global Rett Syndrome Market, pest analysis
• FIG 8. Global Rett Syndrome Market, value chain analysis
• FIG 9. Global Rett Syndrome Market by segment, 2018 & 2028 (USD Million)
• FIG 10. Global Rett Syndrome Market by segment, 2018 & 2028 (USD Million)
• FIG 11. Global Rett Syndrome Market by segment, 2018 & 2028 (USD Million)
• FIG 12. Global Rett Syndrome Market by segment, 2018 & 2028 (USD Million)
• FIG 13. Global Rett Syndrome Market by segment, 2018 & 2028 (USD Million)
• FIG 14. Global Rett Syndrome Market, regional snapshot 2018 & 2028
• FIG 15. North America Rett Syndrome Market 2018 & 2028 (USD Million)
• FIG 16. Europe Rett Syndrome Market 2018 & 2028 (USD Million)
• FIG 17. Asia pacific Market 2018 & 2028 (USD Million)
• FIG 18. Latin America Rett Syndrome Market 2018 & 2028 (USD Million)
• FIG 19. Global Rett Syndrome Market, company Market share analysis (2021)